Phage therapy for COVID19 patients has been approved by the FDA. Adaptive Phage Therapeutics given a green light to Expanded Access IND to use phage therapy for critical COVID19 patients.
Phage therapy for COVID19 patients has been approved by the FDA. Adaptive Phage Therapeutics given a green light to Expanded Access IND to use phage therapy for critical COVID19 patients.